85 results on '"del Carmen, Marcela G."'
Search Results
2. Narrowing inequity gap: ERAS home delivery kit
3. Trends in the use of neoadjuvant chemotherapy for low-grade serous ovarian cancer in the United States
4. Race, ethnicity, sex, and socioeconomic disparities in anticoagulation for atrial fibrillation: A narrative review of contemporary literature
5. Association of hospital-level factors with utilization of sentinel lymph node biopsy in patients with early-stage vulvar cancer
6. Intraoperative Deaths: Who, Why, and Can We Prevent Them?
7. Lymph node assessment at the time of hysterectomy has limited clinical utility for patients with pre-cancerous endometrial lesions
8. Wellness Program Implementation in an Academic Radiology Department: Determination of Need, Organizational Buy-in, and Outcomes
9. Patient reported outcome measures among patients with vulvar cancer at various stages of treatment, recurrence, and survivorship
10. Neoadjuvant chemotherapy does not disproportionately influence post-operative complication rates or time to chemotherapy in obese patients with advanced-stage ovarian cancer
11. Does the Day of the Week Predict a Cesarean Section? A Statewide Analysis
12. Infection, thrombosis, and oncologic outcome after interval debulking surgery: Does perioperative blood transfusion matter?
13. Variation in resource utilization associated with the surgical management of ovarian cancer
14. Isolated para-aortic lymph node metastasis in FIGO stage IA2-IB2 carcinoma of the cervix: Revisiting the role of surgical assessment
15. Moving beyond “complete surgical resection” and “optimal”: Is low-volume residual disease another option for primary debulking surgery?
16. Thirty-day unplanned hospital readmission in ovarian cancer patients undergoing primary or interval cytoreductive surgery: systematic literature review
17. Racial and ethnic disparities over time in the treatment and mortality of women with gynecological malignancies
18. Intensive care admissions among ovarian cancer patients treated with primary debulking surgery and neoadjuvant chemotherapy-interval debulking surgery
19. Associations between residual disease and survival in epithelial ovarian cancer by histologic type
20. Management of menopausal symptoms in women with gynecologic cancers
21. Ovarian cancer spheroid shrinkage following continuous exposure to cisplatin is a function of spheroid diameter
22. Disparities in receipt of care for high-grade endometrial cancer: A National Cancer Data Base analysis
23. Trends in the use of neoadjuvant chemotherapy for advanced ovarian cancer in the United States
24. “Carcinosarcoma of the ovary, fallopian tube, and peritoneum: Prognostic factors and treatment modalities”
25. Variation in care in concurrent chemotherapy administration during radiation for locally advanced cervical cancer
26. Patterns of care, predictors and outcomes of chemotherapy for ovarian carcinosarcoma: A National Cancer Database analysis
27. The Role of Endometrial Biopsy in the Preoperative Detection of Uterine Leiomyosarcoma
28. Readmissions after major gynecologic oncology surgery
29. Risk Factors for Occult Uterine Sarcoma Among Women Undergoing Minimally Invasive Gynecologic Surgery
30. Increasing NIH funding for academic departments of obstetrics and gynecology: a call to action
31. Sustained, low-dose intraperitoneal cisplatin improves treatment outcome in ovarian cancer mouse models
32. Progress and remaining challenges for cancer control in Latin America and the Caribbean
33. Patterns of care, associations and outcomes of chemotherapy for uterine serous carcinoma: Analysis of the National Cancer Database
34. Patterns of care, predictors and outcomes of chemotherapy for uterine carcinosarcoma: A National Cancer Database analysis
35. Delay in chemotherapy administration impacts survival in elderly patients with epithelial ovarian cancer
36. Global health perspective on gynecologic oncology
37. Surgical Apgar Score and prediction of morbidity in women undergoing hysterectomy for malignancy
38. Tumor size, depth of invasion, and histologic grade as prognostic factors of lymph node involvement in endometrial cancer: A SEER analysis
39. Transitional cell carcinoma of the ovary: A case–control study
40. Comparison of clinical outcomes of patients with clear cell and endometrioid ovarian cancer associated with endometriosis to papillary serous carcinoma of the ovary
41. The value of re-exploration in patients with inadvertently morcellated uterine sarcoma
42. A novel classification of residual disease after interval debulking surgery for advanced-stage ovarian cancer to better distinguish oncologic outcome
43. Race, Ethnicity, and Income Factors Impacting Human Papillomavirus Vaccination rates
44. Carcinosarcoma of the ovary compared to papillary serous ovarian carcinoma: A SEER analysis
45. Platinum resistance after neoadjuvant chemotherapy compared to primary surgery in patients with advanced epithelial ovarian carcinoma
46. Uterine papillary serous cancer: A review of the literature
47. A phase II clinical trial of pegylated liposomal doxorubicin and carboplatin plus bevacizumab in patients with platinum-sensitive recurrent ovarian, fallopian tube, or primary peritoneal cancer
48. Clear cell carcinoma of the ovary: A review of the literature
49. Prognostic determinants in patients with uterine and ovarian clear carcinoma
50. Changes in serum CA-125 can predict optimal cytoreduction to no gross residual disease in patients with advanced stage ovarian cancer treated with neoadjuvant chemotherapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.